303 related articles for article (PubMed ID: 32001246)
1. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of nerve growth factor in cholestatic livers and its hepatoprotective role against oxidative stress.
Tsai MS; Lin YC; Sun CK; Huang SC; Lee PH; Kao YH
PLoS One; 2014; 9(11):e112113. PubMed ID: 25397406
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target.
Tsai MS; Lee PH; Sun CK; Chiu TC; Lin YC; Chang IW; Chen PH; Kao YH
Exp Mol Med; 2018 Jan; 50(1):e426. PubMed ID: 29328070
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis reveals a positive role for nerve growth factor in retinol metabolism in primary rat hepatocytes.
Kao YH; Lee PH; Chiu TC; Lin YC; Sun CK; Chen PH; Tsai MS
Cytokine; 2018 Jul; 107():74-78. PubMed ID: 29217403
[TBL] [Abstract][Full Text] [Related]
5. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
Liu Y; Binz J; Numerick MJ; Dennis S; Luo G; Desai B; MacKenzie KI; Mansfield TA; Kliewer SA; Goodwin B; Jones SA
J Clin Invest; 2003 Dec; 112(11):1678-87. PubMed ID: 14623915
[TBL] [Abstract][Full Text] [Related]
7. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
8. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
[TBL] [Abstract][Full Text] [Related]
9. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.
Li WT; Luo QQ; Wang B; Chen X; Yan XJ; Qiu HY; Chen SL
FASEB J; 2019 Feb; 33(2):2435-2450. PubMed ID: 30260705
[TBL] [Abstract][Full Text] [Related]
10. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
[TBL] [Abstract][Full Text] [Related]
12. FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
Panzitt K; Jungwirth E; Krones E; Lee JM; Pollheimer M; Thallinger GG; Kolb-Lenz D; Xiao R; Thorell A; Trauner M; Fickert P; Marschall HU; Moore DD; Wagner M
J Hepatol; 2020 Jun; 72(6):1122-1131. PubMed ID: 32001325
[TBL] [Abstract][Full Text] [Related]
13. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
Wei X; Ma Y; Dong Z; Wang G; Lan X; Liao Z; Chen M
Phytomedicine; 2021 Jan; 80():153378. PubMed ID: 33113499
[TBL] [Abstract][Full Text] [Related]
14. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
[TBL] [Abstract][Full Text] [Related]
15. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
[TBL] [Abstract][Full Text] [Related]
16. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver.
Wang B; Zhang H; Luan Z; Xu H; Wei Y; Zhao X; Xing M; Huo X; Zhang J; Su W; Guan Y; Zhang X
Exp Cell Res; 2020 May; 390(1):111949. PubMed ID: 32145254
[TBL] [Abstract][Full Text] [Related]
18. Suppression of autophagic flux by bile acids in hepatocytes.
Manley S; Ni HM; Kong B; Apte U; Guo G; Ding WX
Toxicol Sci; 2014 Feb; 137(2):478-90. PubMed ID: 24189133
[TBL] [Abstract][Full Text] [Related]
19. Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes.
Li X; Liu R; Yu L; Yuan Z; Sun R; Yang H; Zhang L; Jiang Z
Toxicology; 2016 Aug; 370():106-115. PubMed ID: 27702592
[TBL] [Abstract][Full Text] [Related]
20. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]